Root causes to solutions: A policy proposal to address generic drug shortages
In the United States, drug shortages have become a persistent public health issue, negatively impacting patient care and outcomes. In the last decade, the...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Engagements
- 01Driving impact from data science and customer profile attributesClient issue A leading pharmaceutical company (top 10 by global revenue) sought to increase the impact of its global data science capability and improve return...View engagement
- 02AAA dispute in commercially reasonable efforts to market a hospital administered drugCRA expert, Dr. Sean Sheridan considered the Respondent’s efforts as they relate to the obligations of the licensing agreement and evaluated those efforts...View engagement
- 03Breach of contract dispute relating to university technology transfer practicesDr. Sean Sheridan provided expert testimony on academic technology transfer practices and responded to the Plaintiff’s expert’s opinions regarding certain...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsUpcoming events
World EPA Congress
CRA is a proud sponsor of the event covering market access, pricing, reimbursement, rare diseases, health technology assessments, health economics and outcomes...
Intellus Worldwide 2025 Summit
CRA is a proud sponsor of the event. Kaitlyn Austin presents the session titled “Securing Insight Alignment to Drive Future-Proofed Strategies and...
Recent events
JP Morgan Panel Discussion - Navigating the New Landscape: What will happen with prices?
It’s been a little over two years since the Inflation Reduction Act (IRA) was enacted. During this period, the first ten products have been negotiated with...
2024 ASHP Midyear Clinical Meeting and Exhibition
This panel will offer economic insights from both Pfizer and non-Pfizer experts, covering the following topics: Identifying economic factors that contribute...